NCT05513937View on ClinicalTrials.gov

Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy

PHASE4CompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

May 12, 2022

Primary Completion Date

November 15, 2022

Study Completion Date

November 15, 2022

Conditions
Hypertension
Interventions
DRUG

Nebivolol

Tablets administered orally once daily according instructions provided by Principal Investigator.

DRUG

Amlodipine

Tablets of 5mg and 10mg administered orally once daily according instructions provided by Principal Investigator.

Trial Locations (1)

1510

Medical Center Hera EOOD, Sofia

All Listed Sponsors
lead

Menarini International Operations Luxembourg SA

INDUSTRY